PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
March 13, 2014 | ISSUE NUMBER 342 VOL 3

Healthcare Reform
“Close Call” for Rx Marketers on Medicare Part D
As the U.S. heads towards a public market place in which Medicare, Medicaid, CHIPs, VA, and now Obamacare will shortly comprise almost 70% of the American healthcare market, American Rx marketers recently endured a “close call” with the U.S. Department of Health and Human Services over the arbitrary deletion of dozens of key drugs from a major American public Rx platform — Medicare Part D ...Read more

Healthcare Reform
Population Health: The Call to Community
Population health is the brick and mortar foundation for much of what is truly new in US health reform. To shed light on this new movement in healthcare, Pharm Exec spoke with one of its leading advocates, Dr. David Nash of the Jefferson Medical University School of Population Health ...Read more

ZS Associates – Genuine Customer Centricity in Sales and Marketing:
You need to embrace all marketing channels, and see which ones work for each customer—instead of playing a single instrument, you need to. conduct an orchestra.

Healthcare Reform
ACA Rollout Raises Ante for Patient Access and Assistance
Amid the looming March 31 deadline for remaining uninsured and underinsured Americans to purchase health insurance mandated by the Affordable Care Act, pharma is emphasizing the importance of enhancing access to medications for the now rapidly expanding patient base, writes Michael Christel.
...Read more

Special Feature
Pharm Exec’s Annual Press Audit 2014
Pharm Exec's latest survey of press issues shows that media coverage continues to remain on balance negative toward the industry, by a slight margin: 47% this year compared to a 46% average over the last seven years
...Read more

NSF Health Sciences Pharma Biotech is your partner to provide world class regulatory and compliance consulting, auditing and training. The team of experts located in the US, Europe and Asia provides a comprehensive range of independent, third-party pharmaceutical and biotech support services. Download the latest quarterly Journal, keeping you up to date on news, views and professional pharmaceutical training. Read more

Strategy
What Do Pharma’s “High Performers” Have in Common?
A new study of high-performing pharma companies reveals science-based innovation strategies and patient-outcome-based commercial models are now the key drivers of growth. Anne O’ Riordan reports
...Read more

Leadership
Pharm Exec’s Emerging Pharma Leaders 2014 — Nominate Now
It's time for you to tell us who you think should receive Pharm Exec's 2014 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself.
...Read more

White Paper – Reprints at the Dawn of the 'Sunshine Act'
Medical journal article reprints provide health care professionals credible clinical evidence that a product works. Read about the new reprint regulations emerging from the Physician Payment Sunshine Act. Learn about newer ePrint formats and discover new distribution channels to get the right article to the right prescriber at the right time. Read more

eBook
Pharmaceutical Executive’s Digital Marketing Three eBook & Video Combo
Pharmaceutical Executive brings you the perfect combination of resources to increase your digital marketing IQ: an eBook with 10 must-read topics and more than four hours of in-depth video presentations by marketing experts Augustine Fou, Mike Moran and Mark Schaefer
...Read more

//Moderna Therapeutics (Cambridge, MA) announced that Lorence Kim, M.D. is to join Moderna’s executive leadership team as Chief Financial Officer, effective April 21.//Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, joined the Board of Directors of Targeted Medical Pharma (Los Angeles, CA).//Infinity Pharmaceuticals, Inc. (Cambridge, MA) appointed José Baselga M.D., Ph.D. and Jeff Berkowitz as independent members of its Board of Directors.//Idera Pharmaceuticals, Inc. (Cambridge, MA) announced that Baker Brothers Investments’ Julian C. Baker and Kelvin M. Neu, M.D., joined its Board of Directors, effective March 10, 2014.//

March 18–20: eyeforpharma Barcelona 2014
Barcelona, Spain.


May 8–9: iPharma 2014
New York, NY.


June 17–18: PAAS 2014 Patient Adherence and Access Summit
Philadelphia, PA


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

FEATURED EVENT
iPharma
The most educationally robust digital marketing forum dedicated to bringing together the biggest movers and shakers in the life-sciences industry.
...Read more

 

Survey
Which key skills do you think the industry most requires?

Click To Vote
 

Quick Links

FDA Details National Vaccine Plan

Track-and Trace Not Enough to Halt Drug Counterfeiters

Knowledge, Motivation, Context: Unlock the True Value of Digital Communications